TAL 1B5 may be used for HLA typing.
| Institute |
|---|
| Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| Cat. #: | 151227 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Immunology |
| Application: | IHC ; ELISA ; FACS ; IHC ; IF ; RIA ; WB |
| Target: | Human Leukocyte Antigen DR, alpha subunit |
| Reactivity: | Human |
| Clone: | TAL 1B5 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | TAL 1B5 may be used for HLA typing. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Molecular weight: | 33 kDa |
| Immunogen: | Bristol 8 separated alpha chain preparation |
| Myeloma used: | P3/NS1/1-Ag4.1 |
| Target background: | Human Leukocyte Antigens are highly polymorphic proteins that are involved in the presentation of antigens to the T-cell receptor. There are two classes of HLA antigens, class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Roher et al. 2013. PLoS One. 8(3):e59735. PMID: 23555764. Bapineuzumab alters a? composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy. Chung et al. 2012. Int J Cancer. 131(3):E227-35. PMID: 22174092. Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer. van Dongen et al. 2010. Int J Cancer. 127(4):899-909. PMID: 20013807. Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors. Thomas et al. 1988. J Pathol. 154(4):353-63. PMID: 2455029. HLA-D region alpha-chain monoclonal antibodies: cross-reaction between an anti-DP alpha-chain antibody and smooth muscle. Adams et al. 1983. Immunology. 50(4):613-24. PMID: 6197354. Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151027 | Anti-HSVICP8 [10A3] |
Key Info
Anti-HSVICP8 [10A3]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151038 | Anti-Cytochrome P450 4A2, 4A3 [Clo4] |
Key Info
Anti-Cytochrome P450 4A2, 4A3 [Clo4]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.